Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation

NCT03014102 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Thrombocytopoietin
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation

Interventions

DRUG: Recombinant Human Thrombopoietin

Sponsor

Hongnan Mo